Functional Communicative Profile of Children With Down Syndrome

This study has been completed.
Sponsor:
Information provided by:
University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT00844259
First received: February 13, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
  Purpose

The aim of this study was to verify the use of communicative functions by children with DS in two interaction conditions: interaction with therapist and interaction with parent.


Condition
Down Syndrome

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Cross-Sectional
Official Title: Functional Communicative Profile of Children With Down Syndrome

Resource links provided by NLM:


Further study details as provided by University of Sao Paulo:

Enrollment: 15
Study Start Date: July 2006
Study Completion Date: October 2007
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
Research Group
15 children with Down syndrome, observed in two interaction conditions: playing with their therapist (A) and playing with their caregiver (B).

Detailed Description:

Parents and caregivers' engagement on therapeutic process of children with Down syndrome (DS) is important for language and communication development. The identification of the communicative skills presented by these children as well as the context influence in their performance as interlocutors, will contribute to the design of therapeutic interventions.

Pragmatics theories are helpful to language use studies, since it takes into account social and environmental aspects and considers adult-child interaction as a determinant factor for its occurrence.

  Eligibility

Ages Eligible for Study:   5 Years to 8 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

15 children with Down syndrome aged from 5 to 8 years.

Criteria

Inclusion Criteria:

  • genetic diagnosis of Down syndrome
  • good health conditions
  • normal results on audiologic evaluation
  • pediatric and ear, nose and throat periodic check ups.
  • attend speech-language therapy at the Speech Language Pathology Laboratory in Syndromes and Sensorimotor Deficits (SLPL-SSD) of the School of Medicine of the University of São Paulo.

Exclusion Criteria:

  • submission to long term hospitalizations due to heart diseases and major respiratory airway infections, that may interfere in the child's global development
  • presence of visual or auditory important deficits
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00844259

Locations
Brazil
University of Sao Paulo - School of Medicine - Department of Physiotherapy, Communication Sciences and Disorders, Occupational Therapy
Sao Paulo, Brazil, 05360-160
Sponsors and Collaborators
University of Sao Paulo
Investigators
Study Chair: Suelly CO Limongi, PhD University of Sao Paulo
Principal Investigator: Eliza P Cunha, Ms student University of Sao Paulo
  More Information

No publications provided

Responsible Party: Suelly Cecilia Olivan Limongi, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT00844259     History of Changes
Other Study ID Numbers: 180875
Study First Received: February 13, 2009
Last Updated: February 13, 2009
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by University of Sao Paulo:
Down syndrome
Pragmatics
Language Development

Additional relevant MeSH terms:
Down Syndrome
Mental Retardation
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Abnormalities, Multiple
Congenital Abnormalities
Chromosome Disorders
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on July 20, 2014